1
Return

ANGPTL3 gene editing with CRISPR-Cas9: early trial insights

delete2026-04-13
delete0
delete
OA
AI
X
Xuan L. Tang
A
Amanda J. Hooper *
J
John R. Burnett *
DOI：10.1080/13543784.2026.2656431delete
deleteOriginal
deleteOriginal request for help
deleteShare
deleteSave
Abstract

Abstract

En
Keywords:
Angiopoietin-like 3
ANGPTL3 inhibitor
apolipoprotein B
CRISPR-Cas9
gene editing
CX310
LDL-cholesterol
triglyceride

Journal

E
Expert Opinion on Investigational Drugs
IF:
4.1
Papers:
3.4K
Citations:
5.7K

Organization

P
pathwest laboratory medicine wa and royal perth hospital and fiona stanley hospital network
Scholars:
1
Papers: 1
Citations: 0
P
Pathwest Laboratory Medicine WA and Royal Perth Hospital and Fiona Stanley Hospital Network
Scholars:
1
Papers: 1
Citations: 0
U
university of western australia
Scholars:
2.1K
Papers: 987
Citations: 0
Cited Papers

Cited Papers

Citing Papers

Citing Papers